Source: International Congress 2019 – New insights into childhood infections: from viral bronchiolitis to bronchiolitis obliterans
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
E. Seidl (Munich, Germany), T. Magg (Munich, Germany), K. Reiter (Munich, Germany), D. Schramm (Düsseldorf, Germany), M. Kappler (Munich, Germany), I. Pawlita (Munich, Germany), J. Ripper (Munich, Germany), M. Feilcke (Munich, Germany), J. Nübling (Munich, Germany), J. Ley-Zaporozhan (Munich, Germany), I. Krüger-Stollfuß (Munich, Germany), B. Kammer (Munich, Germany), C. Walz (Munich, Germany), S. Reu (Würzburg, Germany), R. Meino (Munich, Germany), C. Klein (Munich, Germany), F. Hauck (Munich, Germany), M. Griese (Munich, Germany). Pulmonary alveolar proteinosis due to heterozygous mutation in OAS1: Treatment of a novel disease with whole lung lavages and stem cell transplantation. 1017

Member's Comments

No comment yet.

Related content which might interest you: Pulmonary alveolar proteinosis due to monocytopenia: Lung transplant or haematopoeitic stem cell transplant? Source: Annual Congress 2012 - Optimising outcomes after lung transplantation Year: 2012 Association of pulmonary alveolar proteinosis and fibrosis: patient with GATA2 deficiency Source: Eur Respir J 2016; 48: 1510-1514 Year: 2016 Pulmonary alveolar proteinosis due to a novel mutation in CSF2RA Source: Annual Congress 2012 - Paediatric bronchology Year: 2012 Establishment of alveolar epithelial progenitor cells from the lung with ABCA3 mutations Source: International Congress 2015 – Pulmonary fibrosis: mechanisms of disease Year: 2015 Pulmonary alveolar proteinosis: iPS derived macrophages as in-vitro disease model and potential source for novel gene and cell therapies Source: Annual Congress 2013 –Preclinical models for the development of new drugs for respiratory diseases Year: 2013 Pulmonary alveolar proteinosis: failure of treatment by bronchoscopic lobar lavages and GM-CSF treatment in a child Source: Eur Respir J 2003; 22: Suppl. 45, 309s Year: 2003 Inhaled GM-CSF in pulmonary alveolar proteinosis (PAP) patient refractory to plasmapheresis combined with multiple whole lung lavages (WLL) Source: International Congress 2016 – Orphan diseases I Year: 2016 Pulmonary alveolar proteinosis Source: Respipedia Article Year: 2017 Pulmonary alveolar proteinosis and Mycobacterium abscessus lung infection related to ruxolitinib after allogeneic stem cell transplantation Source: Eur Respir J, 51 (5) 1701960; 10.1183/13993003.01960-2017 Year: 2018 MUC1 gene polymorphisms are associated with serum KL-6 levels and pulmonary dysfunction in pulmonary alveolar proteinosis Source: Annual Congress 2013 –Diffuse parenchymal lung disease I Year: 2013 Lung transplantation in telomerase mutation carriers with pulmonary fibrosis Source: Eur Respir J 2014; 44: 178-187 Year: 2014 Whole lung lavage efficacy in pulmonary alveolar proteinosis (PAP) is influenced by the infusion volume? Source: International Congress 2015 – IIPs: orphan Year: 2015 Early effect of whole lung lavage (WLL) on surfactant homeostasis in pulmonary alveolar proteinosis (PAP) Source: International Congress 2014 – ILDs: diagnostic and prognostic investigations Year: 2014 Inhaled sargramostim and whole lung lavage (WLL) as therapy of autoimmune pulmonary alveolar proteinosis (aPAP) Source: International Congress 2016 – Orphan diseases I Year: 2016 Is it possible to predict the outcome of the whole lung lavage (WLL) in pulmonary alveolar proteinosis (PAP)? Source: International Congress 2015 – IIPs: orphan Year: 2015 Determinants of protein concentration in whole lung lavage of patients with pulmonary alveolar proteinosis Source: Annual Congress 2009 - From genetics to clinics in diffuse parenchymal lung diseases Year: 2009 Idiopathic pulmonary alveolar proteinosis: GM CSF therapy and whole lung lavage a case report Source: Eur Respir J 2003; 22: Suppl. 45, 44s Year: 2003 Serum biomarkers as prognostic factors of autoimmune pulmonary alveolar proteinosis after whole lung lavage Source: International Congress 2016 – Orphan diseases I Year: 2016 Intrapulmonary transplantation of macrophage progenitors as long-lasting therapy for hereditary pulmonary alveolar proteinosis Source: International Congress 2014 – Bronchoscopy in peripheral pulmonary lesions and diffuse lung diseases Year: 2014 Interstitial lung disease in a baby with a de novo mutation in the SFTPC gene Source: Eur Respir J 2004; 24: 30-39 Year: 2004